Vanguard Group Inc Esperion Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,715,748 shares of ESPR stock, worth $21.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,715,748

Previous 13,043,077 10.18%

Holding current value

$21.7 Million

Previous $21.5 Million 19.76%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$1.61 - $3.83 $2.14 Million - $5.08 Million	-1,327,329 Reduced 10.18%	11,715,748 $25.8 Million
Q3 2024 Nov 13, 2024	BUY	$1.61 - $2.73 $3.58 Million - $6.08 Million	2,226,315 Added 20.58%	13,043,077 $21.5 Million
Q2 2024 Aug 13, 2024	BUY	$1.84 - $3.24 $3.66 Million - $6.45 Million	1,990,216 Added 22.55%	10,816,762 $24 Million
Q1 2024 May 10, 2024	BUY	$2.02 - $3.02 $7.45 Million - $11.1 Million	3,688,796 Added 71.8%	8,826,546 $23.7 Million
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $289,363 - $1.22 Million	396,388 Added 8.36%	5,137,750 $15.4 Million
Q3 2023 Nov 14, 2023	BUY	$0.96 - $1.79 $458,973 - $855,793	478,097 Added 11.21%	4,741,362 $4.65 Million
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $66,268 - $97,194	-55,224 Reduced 1.28%	4,263,265 $5.93 Million
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $84,716 - $423,582	58,025 Added 1.36%	4,318,489 $6.87 Million
Q4 2022 Feb 10, 2023	BUY	$5.09 - $8.5 $1.13 Million - $1.89 Million	221,939 Added 5.5%	4,260,464 $26.5 Million
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $1.4 Million - $2.09 Million	-257,673 Reduced 6.0%	4,038,525 $27.1 Million
Q2 2022 Aug 12, 2022	SELL	$4.77 - $6.67 $931,733 - $1.3 Million	-195,332 Reduced 4.35%	4,296,198 $27.3 Million
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $2.44 Million - $4.06 Million	730,091 Added 19.41%	4,491,530 $20.8 Million
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $9.24 Million - $22.9 Million	1,921,196 Added 104.4%	3,761,439 $18.8 Million
Q3 2021 Nov 12, 2021	SELL	$11.34 - $21.37 $5.21 Million - $9.82 Million	-459,745 Reduced 19.99%	1,840,243 $22.2 Million
Q2 2021 Aug 13, 2021	BUY	$19.4 - $28.71 $44.6 Million - $66 Million	2,299,988 New	2,299,988 $48.6 Million

Others Institutions Holding ESPR

# of Institutions

215

Shares Held

129M

Call Options Held

1.78M

Put Options Held

1.27M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $123M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Esperion Therapeutics, Inc. Transaction History